1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 06 JULY 2015

Cancer Drug News 06 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Bespoke Medicine Success Reliant On Manufacturing Efficiences
Industry Trend Analysis - Cost Will Impact Perjeta's Success In Europe
Industry Brief - Takeda's Adcetris First Ultra-Orphan Medicine Recommended By AWMSG
Industry Brief - CHMP Adopts Positive Opinion On Novartis' Farydak For MM
Industry Brief - Opdivo Becomes First LC Treatment Approved Under UK EAMS
Industry Trend Analysis - Lilly Alimta Appeal Win To Push Back Generic Competition
Industry Trend Analysis - Clovis Still Faces AstraZeneca Threat After Filing First
Industry Trend Analysis - Increased Targeting Will Lead To Super Niche Cancer Markets
Industry Brief - Telesta Submits BLA For MCNA To FDA
Industry Brief - Immunovaccine/Incyte Collaborate On Immunotherapy Combination
Industry Brief - PharmaMar Initiates Phase III Study Of PM1183 In Platinum-Resistant OC
Industry Brief - AEterna Zentaris Completes Enrolment In Zoptarelin Doxorubicin Phase III Trial
Industry Brief - MM-398 Receives FDA Priority Review Designation; Acceptance Of EU MAA
Industry Trend Analysis - Array's BRAF Inhibitor Success Relies On Differentiation
Industry Brief - Immunocore/Lilly Enter Immunotherapy Combination Trial Collaboration In Melanoma
Industry Trend Analysis - Cobimetinib/Zelboraf Combination Will Gain Delayed FDA Approval
Industry Brief - Eisai Launches Lenvima In Nordic Region For RAI-Refractory DTC
Industry Trend Analysis - Continuous Manufacturing Represents Future Of Pharmaceutical Production
Industry Brief - Peregrine Granted Key European Patent For Bavituximab
Industry Trend Analysis - Cancer Drug Pricing To Remain In Firing Line
Industry Brief - ViraTherapeutics Raises Funds To Advance Novel Oncolytic Virus Platform
Industry Brief - Provectus/Boehringer Collaborate To Bring PV-10 Into China
Industry Brief - Zosyn Receives Japanese Approval For Febrile Neutropenia
Industry Brief - Phase III Study Of Single-Dose Emend For Injection Regimen Meets Primary Endpoint
Industry Trend Analysis - Increased CAR-T Investment View Playing Out
Industry Brief - Panther To Acquire Alchemia Oncology
Industry Brief - Baxalta Launched To Deliver Therapies For Orphan Diseases And Underserved Conditions
Industry Brief - Medigene Raises Funds To Accelerate Cancer Immunotherapy Programmes

Table Of Contents

Cancer Drug News 06 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.